T-PORT Trademark

Trademark Overview

On Wednesday, May 25, 2022, a trademark application was filed for T-PORT with the United States Patent and Trademark Office. The USPTO has given the T-PORT trademark a serial number of 79343431. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, August 12, 2024. This trademark is owned by Transcutan AB. The T-PORT trademark is filed in the Medical Instrument Products category with the following description:

Apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; valves for providing transcutaneous access to the blood circulation and the gastrointestinal tract and for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; implantable apparatus in the nature of implantable access device for providing transcutaneous access to the blood circulation and the gastrointestinal tract and for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract
t-port

General Information

Serial Number79343431
Word MarkT-PORT
Filing DateWednesday, May 25, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, August 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesApparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; valves for providing transcutaneous access to the blood circulation and the gastrointestinal tract and for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; implantable apparatus in the nature of implantable access device for providing transcutaneous access to the blood circulation and the gastrointestinal tract and for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, June 24, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTranscutan AB
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSE

Trademark Events

Event DateEvent Description
Thursday, June 23, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Friday, June 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 28, 2022APPLICATION FILING RECEIPT MAILED
Friday, October 14, 2022INTERNATIONAL REGISTRATION RENEWED
Tuesday, March 14, 2023ASSIGNED TO EXAMINER
Friday, March 17, 2023NON-FINAL ACTION WRITTEN
Saturday, March 18, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, May 8, 2023REFUSAL PROCESSED BY MPU
Monday, May 8, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 6, 2023REFUSAL PROCESSED BY IB
Wednesday, November 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, November 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, December 18, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, January 29, 2024NON-FINAL ACTION WRITTEN
Monday, January 29, 2024NON-FINAL ACTION E-MAILED
Monday, January 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 12, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 12, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, August 12, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 12, 2025FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 29, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 7, 2025NEW REPRESENTATIVE AT IB RECEIVED
Thursday, July 16, 2026NEW REPRESENTATIVE AT IB RECEIVED
Thursday, July 16, 2026NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

port circulation gastrointestinal blood tract transcutaneous access nutrients dosing medicines apparatus